Skip to main content
. 2019 Nov 30;3(12):e10239. doi: 10.1002/jbm4.10239

Table 2.

Area Under the Receiver Operating Characteristic Curve Values for Fracture Risk Assessment Tool (FRAX) Alone and FRAX with Additional Clinical Characteristics on Predicted 10‐Year Risk of Fracture

Hip fracture Major osteoporotic fracture
Modela n AUC (95% CI) n AUC (95% CI)
All participants
Age 92,075 77.1 (76.0–78.2) 94,413 64.7 (64.1–65.2)
Age + BMI 92,075 77.4 (76.3–78.4) 94,413 64.6 (64.1–65.2)
Age + history of fracture (any site) 92,075 77.1 (76.1–78.2) 94,413 65.2 (64.6–65.7)
FRAX alone (all participants) 92,075 76.2 (75.1–77.3) 94,413 65.0 (64.5–65.6)
FRAX alone (white participants) 79,909 75.4 (74.3–76.6) 81,947 64.2 (63.6–64.8)
FRAX alone (black participants) 6194 81.2 (74.5–88.0) 6903 60.6 (57.5–63.7)
FRAX + treated diabetes 92,075 76.5 (75.4–77.5) 94,413 65.3 (64.8–65.9)
FRAX + ≥2 falls in the past year 92,075 75.4 (74.3–76.5) 94,413 65.3 (64.8–65.9)
FRAX + vasomotor symptoms 92,075 74.8 (73.6–76.0) 94,413 65.0 (64.4–65.5)
FRAX + physical function 92,075 75.9 (74.9–77.0) 94,413 66.2 (65.6–66.7)
FRAX + all additional factors 92,075 76.2 (75.1–77.3) 94,413 66.6 (66.0–67.1)
BMD subset
Age 5541 76.1 (72.1–80.2) 5722 66.2 (64.1–68.3)
Age + BMI 5541 76.3 (72.2–80.4) 5722 66.2 (64.1–68.3)
Age + history of fracture (any site) 5541 76.4 (72.5–80.4) 5722 67.4 (65.3–69.5)
FRAX alone (all participants) 5541 77.6 (73.7–81.5) 5722 69.8 (67.8–71.8)
FRAX alone (white participants) 4537 77.0 (72.8–81.1) 4695 68.3 (66.1–70.5)
FRAX alone (black participants) 663 84.5 (69.2–99.9) 672 65.6 (55.6–75.6)
FRAX + treated diabetes 5541 77.2 (73.1–81.2) 5722 70.2 (68.2–72.1)
FRAX + ≥2 falls in the past year 5541 76.6 (72.6–80.7) 5722 70.0 (68.0–72.0)
FRAX + vasomotor symptoms 5541 76.4 (72.1–80.7) 5722 69.8 (67.8–71.8)
FRAX + physical function 5541 77.3 (73.4–81.2) 5722 70.7 (68.7–72.7)
FRAX + lumbar spine BMD 5541 75.9 (71.7–80.1) 5722 70.0 (68.0–71.9)
FRAX + all additional factors 5541 77.7 (73.4–81.9) 5722 71.4 (69.4–73.4)
a

All models are adjusted for intervention assignment in the WHI Hormone (Active, Placebo, not Randomized) and Calcium Vitamin D (Active, Placebo, Not Randomized) trials.